Evidence map›Paper›PMID 40697815›Full record

ArticleFrontiers in cellular and infection microbiology2025

Tejasri Yarlagadda, Jacob Stedman, Diane Maresco-Pennisi, Andrea Coleman, Anders Cervin, Kirsten Spann

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. CombinedInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tejasri YarlagaddaCentre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Jacob StedmanCentre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Diane Maresco-PennisiThe Ear, Nose and Throat (ENT) Research Group, Centre for Clinical Research, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, QLD, Australia.
Andrea ColemanThe Ear, Nose and Throat (ENT) Research Group, Centre for Clinical Research, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, QLD, Australia.
Anders CervinThe Ear, Nose and Throat (ENT) Research Group, Centre for Clinical Research, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, QLD, Australia.
Kirsten SpannCentre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Respiratory syncytial virus (RSV) infection in the upper respiratory tract promotes disease progression and transmission, with excessive inflammation contributing to severe lower respiratory tract involvement. This study investigates the immunomodulatory effects of Methods: WD-NECs from healthy adult donors (N = 8) were cultured Results: RSV infection induced robust viral replication and shedding, disrupted epithelial barrier integrity, and triggered the release of pro-inflammatory cytokines and type I/III interferons. Discussion:

Indexed as

Epithelial CellsLacticaseibacillus rhamnosusNasal MucosaRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsVirus SheddingAdultAntiviral AgentsCells, CulturedCytokinesHumansImmunity, InnateInflammationProbioticsVirus ReplicationAntiviral AgentsCytokinesantiviralinflammationinnate immunitylactobacillinasal epitheliumrespiratory syncytial virus

Identifiers

PMID40697815
PMCPMC12279880

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.